Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

NASDAQ:DORM - Nasdaq - US2582781009 - Common Stock - Currency: USD

107.29  -3.89 (-3.5%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to DORM. DORM was compared to 81 industry peers in the Automobile Components industry. DORM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DORM has a correct valuation and a medium growth rate. These ratings could make DORM a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DORM was profitable.
DORM had a positive operating cash flow in the past year.
In the past 5 years DORM has always been profitable.
Each year in the past 5 years DORM had a positive operating cash flow.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

With an excellent Return On Assets value of 7.84%, DORM belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
With an excellent Return On Equity value of 14.69%, DORM belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
DORM has a Return On Invested Capital of 11.79%. This is amongst the best in the industry. DORM outperforms 92.59% of its industry peers.
DORM had an Average Return On Invested Capital over the past 3 years of 9.34%. This is in line with the industry average of 8.88%.
The last Return On Invested Capital (11.79%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.84%
ROE 14.69%
ROIC 11.79%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 9.46%, DORM belongs to the top of the industry, outperforming 96.30% of the companies in the same industry.
In the last couple of years the Profit Margin of DORM has grown nicely.
DORM's Operating Margin of 14.58% is amongst the best of the industry. DORM outperforms 98.77% of its industry peers.
In the last couple of years the Operating Margin of DORM has grown nicely.
With an excellent Gross Margin value of 40.13%, DORM belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 14.58%
PM (TTM) 9.46%
GM 40.13%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

DORM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DORM has less shares outstanding than it did 1 year ago.
DORM has less shares outstanding than it did 5 years ago.
DORM has a better debt/assets ratio than last year.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 4.11 indicates that DORM is not in any danger for bankruptcy at the moment.
DORM has a Altman-Z score of 4.11. This is amongst the best in the industry. DORM outperforms 87.65% of its industry peers.
The Debt to FCF ratio of DORM is 2.51, which is a good value as it means it would take DORM, 2.51 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.51, DORM belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that DORM is not too dependend on debt financing.
DORM has a Debt to Equity ratio of 0.35. This is in the lower half of the industry: DORM underperforms 65.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.51
Altman-Z 4.11
ROIC/WACC1.31
WACC8.98%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.43. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
DORM has a Current ratio of 2.43. This is in the better half of the industry: DORM outperforms 79.01% of its industry peers.
A Quick Ratio of 1.17 indicates that DORM should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.17, DORM is in the better half of the industry, outperforming 72.84% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 1.17
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.27%, which is quite impressive.
DORM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.83% yearly.
DORM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.11%.
The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)57.27%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%40.13%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.99%

3.2 Future

DORM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.24% yearly.
Based on estimates for the next years, DORM will show a small growth in Revenue. The Revenue will grow by 4.83% on average per year.
EPS Next Y9.86%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.75%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.03, which indicates a correct valuation of DORM.
Compared to the rest of the industry, the Price/Earnings ratio of DORM is on the same level as its industry peers.
DORM is valuated rather cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 13.68 indicates a correct valuation of DORM.
DORM's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.32. DORM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.03
Fwd PE 13.68
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than the industry average as 75.31% of the companies are valued more cheaply.
DORM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 17.11
EV/EBITDA 10.89
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
DORM has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.52
PEG (5Y)0.69
EPS Next 2Y9.24%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (4/21/2025, 1:38:08 PM)

107.29

-3.89 (-3.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-05 2025-05-05/bmo
Inst Owners81.24%
Inst Owner Change0.32%
Ins Owners14.98%
Ins Owner Change-7.51%
Market Cap3.28B
Analysts82
Price Target141.01 (31.43%)
Short Float %2.22%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.73%
Min EPS beat(2)9.67%
Max EPS beat(2)25.8%
EPS beat(4)4
Avg EPS beat(4)32.28%
Min EPS beat(4)9.67%
Max EPS beat(4)55.86%
EPS beat(8)5
Avg EPS beat(8)9.5%
EPS beat(12)6
Avg EPS beat(12)5.52%
EPS beat(16)7
Avg EPS beat(16)3.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-3.19%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-2.96%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)0.37%
PT rev (1m)0%
PT rev (3m)2.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.33%
EPS NY rev (1m)2.16%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 15.03
Fwd PE 13.68
P/S 1.63
P/FCF 17.11
P/OCF 14.19
P/B 2.53
P/tB 5.73
EV/EBITDA 10.89
EPS(TTM)7.14
EY6.65%
EPS(NY)7.84
Fwd EY7.31%
FCF(TTM)6.27
FCFY5.84%
OCF(TTM)7.56
OCFY7.05%
SpS65.75
BVpS42.33
TBVpS18.73
PEG (NY)1.52
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 14.69%
ROCE 15.74%
ROIC 11.79%
ROICexc 12.16%
ROICexgc 20.15%
OM 14.58%
PM (TTM) 9.46%
GM 40.13%
FCFM 9.54%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score8
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 2.51
Debt/EBITDA 1.3
Cap/Depr 69.53%
Cap/Sales 1.96%
Interest Coverage 7.57
Cash Conversion 66.09%
Profit Quality 100.85%
Current Ratio 2.43
Quick Ratio 1.17
Altman-Z 4.11
F-Score8
WACC8.98%
ROIC/WACC1.31
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)57.27%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%40.13%
EPS Next Y9.86%
EPS Next 2Y9.24%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.99%
Revenue Next Year4.75%
Revenue Next 2Y4.83%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.08%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year29.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y16.29%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y10.68%
OCF growth 3Y32.07%
OCF growth 5Y19.38%